Bio-Implants Market to Reach $263.8 Billion by 2035

Bio-Implants Market is projected to reach $136.6 billion by 2035, growing from $263.8 billion in 2025 at a steady CAGR of 6.8% during the forecast period. The market growth is primarily driven by the rising prevalence of chronic diseases, increasing ageing population, and advancements in implant technologies across orthopaedic, cardiovascular, and dental applications. One of the key macro drivers fuelling the market is the growing burden of musculoskeletal and cardiovascular diseases globally. According to the World Health Organisation (WHO), musculoskeletal conditions affect approximately 1.71 billion people worldwide, making them the leading contributor to disability.

Browse the full report description of “Bio-Implants Market Size, Share & Trends Analysis Report, By Product Type (Orthopaedic, Cardiovascular, Dental, Neurological, Ophthalmic, and Cosmetic & Reconstructive), By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials), By Application (Orthopedic, Cardiovascular Treatment, Dental Restoration, Neurological Disorders, Ophthalmic Correction, and Cosmetic & Reconstructive Procedures), and By Fixation Type (Cemented Implants, Cementless Implants, and Hybrid Fixation), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/bio-implants-market

Government-backed healthcare investments and increasing access to surgical procedures are further contributing to market growth. According to the Organisation for Economic Co-operation and Development (OECD), healthcare expenditure across member countries has been steadily increasing, averaging around 9–10% of GDP, enabling broader adoption of advanced medical technologies, including bioimplants. The market is also benefiting from technological advancements such as 3D-printed implants, bioresorbable materials, and minimally invasive surgical techniques. These innovations are improving patient outcomes, reducing recovery time, and enhancing the overall efficiency of implant procedures.

Additionally, cardiovascular diseases account for nearly 17.9 million deaths annually, representing around 32% of global deaths. This significant disease burden directly drives demand for bioimplants such as joint replacements, cardiac stents, and pacemakers. The increasing number of surgical procedures globally, supported by healthcare infrastructure expansion, further strengthens the adoption of advanced implant solutions. Among product types, Orthopaedic Implants represent the fastest-growing segment due to the rising incidence of osteoarthritis, fractures, and sports injuries. The ageing population is a major factor, as older adults are more prone to joint degeneration and bone-related disorders. According to WHO estimates, the global population aged 60 years and above is expected to reach 2.1 billion by 2050, significantly boosting demand for joint replacement procedures such as hip and knee implants. Several strategic developments have further strengthened the market landscape. Key industry developments include:

•  In September 2025, Smith+Nephew unveiled major clinical evidence and expanded patient access for its REGENETEN™ Bioinductive Implant, reinforcing its bioimplant product’s real-world performance and availability globally.

• In February 2026, Zimmer Biomet Holdings, Inc. announced that it will release new clinical and operational data and showcase its latest orthopedic implant innovations (including advanced robotic and smart implant technologies such as ROSA Knee with OptimiZe and Persona IQ) at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting, highlighting continued product leadership in the bioimplant/orthopedic segment.

Market Coverage

• The market number available for – 2025-2035
  • Base year- 2025
  • Forecast period- 2026-2035
• Segment Covered-

o By Product Type
o By Application Type
o By Material Type
o By Fixation Type

• Competitive Landscape – Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), and Abbott Laboratories.

Key questions addressed by the report.

• What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Bio-Implants Market Report Segment

By Product Type

• Orthopaedic
  • Cardiovascular
  • Dental
  • Neurological
  • Ophthalmic
  • Cosmetic & Reconstructive

By Material Type

• Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials

By Application

• Orthopedic
  • Cardiovascular Treatment
  • Dental Restoration
  • Neurological Disorders
  • Ophthalmic Correction
  • Cosmetic & Reconstructive Procedures

By Fixation Type

• Cemented Implants
  • Cementless Implants
  • Hybrid Fixation

Global Bio-Implants Market Report Segment by Region

North America

• United States
  • Canada

Europe

• UK
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe

Asia-Pacific

• China
  • India
  • Japan
  • South Korea
  • Australia and New Zealand
  • ASEAN Economies
  • Rest of Asia-Pacific

Rest of the World

• Latin America
  • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bio-implants-market